Reaktionsgleichung
Cl[C:2]1[N:7]=[CH:6][N:5]=[C:4]([C:8]([NH:10][C:11]2[CH:12]=[C:13]3[C:17](=[CH:18][CH:19]=2)[NH:16][N:15]=[CH:14]3)=[O:9])[CH:3]=1.[CH2:20]([NH:23][CH:24]([CH3:26])[CH3:25])[CH2:21][CH3:22]>>[NH:16]1[C:17]2[C:13](=[CH:12][C:11]([NH:10][C:8]([C:4]3[CH:3]=[C:2]([N:23]([CH:24]([CH3:26])[CH3:25])[CH2:20][CH2:21][CH3:22])[N:7]=[CH:6][N:5]=3)=[O:9])=[CH:19][CH:18]=2)[CH:14]=[N:15]1Komponenten
3
Versuchsvorschrift
Following the general method as outlined in Example 20, starting from 6-chloro-pyrimidine-4-carboxylic acid (1H-indazol-5-yl)-amide (Intermediate 16) and propyl-isopropylamine (Matrix), the title compound was obtained as a white solid.
Quellen und Nachweise
- ORD-Eintrag
- ord-df8567d0899f4486a20bb2c5269c683f
- Quelldatensatz
- uspto-grants-2013_03
- Patentnummer
- US08399448B2
Verknüpfte Notizen
Wird geladen…